Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Mira Pharmaceuticals Inc (MIRA)

Mira Pharmaceuticals Inc (MIRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 20,950
  • Shares Outstanding, K 16,561
  • Annual Sales, $ 0 K
  • Annual Income, $ -11,980 K
  • EBIT $ -8 M
  • EBITDA $ -7 M
  • 60-Month Beta 3.09
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 5.83

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.19
  • Number of Estimates 1
  • High Estimate -0.19
  • Low Estimate -0.19
  • Prior Year -0.19
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.0400 +21.63%
on 10/23/24
2.5600 -50.59%
on 10/30/24
+0.1650 (+15.00%)
since 10/18/24
3-Month
1.0200 +24.02%
on 10/16/24
2.7000 -53.15%
on 08/26/24
-0.6750 (-34.79%)
since 08/20/24
52-Week
0.5100 +148.04%
on 07/03/24
5.0400 -74.90%
on 11/21/23
-3.3850 (-72.80%)
since 11/20/23

Most Recent Stories

More News
MIRA Reveals Innovative Phase I/IIa Protocol Design and Selection of Clinical Trial Site

Backed by a Strong Balance Sheet, MIRA Accelerates Toward Becoming a Clinical-Stage Company and Advancing Breakthroughs in Pain and Depression Treatment

MIRA : 1.2650 (-9.64%)
Hope for Chemo Patients: New Pre-Clinical Study Shows Mira Pharmaceuticals Ketamir-2 Beats Competitors' Chemo Pain Reduction by Over 60%

MIRA Pharmaceuticals' novel oral ketamine analog, Ketamir-2, has shown superior efficacy in reducing neuropathic pain compared to leading treatments like Gabapentin and Pregabalin, with the p

MIRA : 1.2650 (-9.64%)
Ketamir-2 from MIRA Pharmaceuticals Raises the Bar in Pain Management, Outshining FDA-Approved Treatments

MIRA Pharmaceuticals' Ketamir-2 shows promise in treating neuropathic pain as a safer and more effective alternative to current medications, with potential applications in mental health as we

MIRA : 1.2650 (-9.64%)
MIRA Pharmaceuticals Aims to Transform Neuropathic Pain Treatment with Ketamir-2

MIRA Pharmaceuticals has announced neuropathic pain as the primary indication for its new oral ketamine analog, Ketamir-2, offering a potential breakthrough in pain management.

MIRA : 1.2650 (-9.64%)
Stock market today: Wall Street slips and breaks an 8-day winning streak

U.S. stocks ticked lower and snapped an eight-day winning streak, the longest of the year

MIRA : 1.2650 (-9.64%)
$SPX : 5,917.11 (unch)
$DOWI : 43,408.47 (+0.32%)
$IUXX : 20,667.10 (-0.08%)
OMH : 0.4023 (-1.88%)
Alaska Air clears a big hurdle in its proposed merger with Hawaiian Airlines

Alaska Air is one step closer to acquiring Hawaiian Airlines after the U.S. Department of Justice chose not to challenge the $1.9 billion deal that the carriers say will create a company better able to...

MIRA : 1.2650 (-9.64%)
NTGR : 24.10 (-0.29%)
AYTU : 1.4900 (-6.59%)
$SPX : 5,917.11 (unch)
$DOWI : 43,408.47 (+0.32%)
$IUXX : 20,667.10 (-0.08%)
Mira Pharmaceuticals Stock Is Soaring In November... Here's Why

Leveraging a favorable DEA classification for its synthetic analog of THC, Mira Pharmaceuticals could be on an expedited pathway toward commercialization to treat several unmet neurological m

MIRA : 1.2650 (-9.64%)
CARA : 0.3050 (+1.36%)
CRBP : 16.08 (-2.90%)
HRMY : 32.79 (+0.95%)
JAZZ : 119.24 (+2.07%)
MIRA Pharmaceuticals Shows its Prescription Pill More Palatable and Potent Than Pot

/PRNewswire/ -- MIRA Pharmaceuticals, Inc. (NASDAQ: MIRA) ("MIRA" or the "Company"), a pre-clinical-stage pharmaceutical company focused on the development and...

MIRA : 1.2650 (-9.64%)
MIRA Pharmaceuticals and MZ Group Partner to Strengthen Investor Relations and Shareholder Communication Efforts

/PRNewswire/ -- MIRA Pharmaceuticals, Inc. (NASDAQ: MIRA) ("MIRA" or the "Company"), a pre-clinical-stage pharmaceutical company focused on the development and...

MIRA : 1.2650 (-9.64%)
MIRA Pharmaceuticals to Participate in 6th Annual Cannabinoid-Derived Drug Development Summit

/PRNewswire/ -- MIRA Pharmaceuticals, Inc. (NASDAQ: MIRA) ("MIRA" or the "Company"), a pre-clinical-stage pharmaceutical company focused on the development and...

MIRA : 1.2650 (-9.64%)

Business Summary

MIRA Pharmaceuticals Inc. operates as a clinical development stage biopharmaceutical company. The company focuses on the development and commercialization of a new molecular synthetic tetrahydrocannabinol analog under investigation for the treatment of adult patients with anxiety and cognitive decline...

See More

Key Turning Points

3rd Resistance Point 1.6867
2nd Resistance Point 1.5483
1st Resistance Point 1.4067
Last Price 1.2650
1st Support Level 1.1267
2nd Support Level 0.9883
3rd Support Level 0.8467

See More

52-Week High 5.0400
Fibonacci 61.8% 3.3095
Fibonacci 50% 2.7750
Fibonacci 38.2% 2.2405
Last Price 1.2650
52-Week Low 0.5100

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar